These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 1381758)

  • 1. Candida onychomycosis--an evaluation of the candida species as primary keratinolytic yeasts in nail disease.
    Qamar AG
    J Pak Med Assoc; 1992 Jun; 42(6):140-3. PubMed ID: 1381758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification, antifungal susceptibility and scanning electron microscopy of a keratinolytic strain of Rhodotorula mucilaginosa: a primary causative agent of onychomycosis.
    da Cunha MM; dos Santos LP; Dornelas-Ribeiro M; Vermelho AB; Rozental S
    FEMS Immunol Med Microbiol; 2009 Apr; 55(3):396-403. PubMed ID: 19170752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morphological evidence for keratinolytic activity of Scopulariopsis spp. isolates from nail lesions and the air.
    Filipello Marchisio V; Fusconi A
    Med Mycol; 2001 Jun; 39(3):287-94. PubMed ID: 11446533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nail Raman spectroscopy: A promising method for the diagnosis of onychomycosis. An ex vivo pilot study.
    Kourkoumelis N; Gaitanis G; Velegraki A; Bassukas ID
    Med Mycol; 2018 Jul; 56(5):551-558. PubMed ID: 29420760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection and differentiation of causative organisms of onychomycosis in an ex vivo nail model by means of Raman spectroscopy.
    Smijs TG; Jachtenberg JW; Pavel S; Bakker-Schut TC; Willemse-Erix D; de Haas ER; Sterenborg H
    J Eur Acad Dermatol Venereol; 2014 Nov; 28(11):1492-9. PubMed ID: 24286616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Onychomycosis in Adana, Turkey: a 5-year study.
    Ilkit M
    Int J Dermatol; 2005 Oct; 44(10):851-4. PubMed ID: 16207188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phospholipase, esterase and hemolytic activities of Candida spp. isolated from onychomycosis and oral lichen planus lesions.
    Pakshir K; Zomorodian K; Karamitalab M; Jafari M; Taraz H; Ebrahimi H
    J Mycol Med; 2013 Jun; 23(2):113-8. PubMed ID: 23706304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Onychomycosis-causing yeasts in four Mexican dermatology centers and their antifungal susceptibility to azolic compounds].
    Manzano-Gayosso P; Méndez-Tovar LJ; Arenas R; Hernández-Hernández F; Millán-Chiu B; Torres-Rodríguez JM; Cortés-González E; Fernández R; López-Martínez R
    Rev Iberoam Micol; 2011; 28(1):32-5. PubMed ID: 21147249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Scopulariopsis brevicaulis: a keratinophilic or a keratinolytic fungus?
    Filipello Marchisio V; Fusconi A; Querio FL
    Mycoses; 2000 Sep; 43(7-8):281-92. PubMed ID: 11036398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Mycological diagnosis of onychomycosis].
    Chabasse D; Pihet M
    J Mycol Med; 2014 Dec; 24(4):269-78. PubMed ID: 25458363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of yeasts in onychomycosis.
    Faergemann J
    Mycoses; 1996; 39(5-6):223-4. PubMed ID: 8909034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Etiopathogenesis, clinical picture and diagnosis of onychomycoses].
    Tasić S; Stojanović S; Poljacki M
    Med Pregl; 2001; 54(1-2):45-51. PubMed ID: 11432322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of K101 Nail Solution on Trichophyton rubrum and Candida albicans growth and ultrastructure.
    Hultenby K; Chryssanthou E; Klingspor L; Rensfeldt K; Strömbeck L; Faergemann J
    Mycoses; 2014 Oct; 57(10):630-8. PubMed ID: 24934317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Onychomycosis in Denmark: prevalence of fungal nail infection in general practice.
    Svejgaard EL; Nilsson J
    Mycoses; 2004 Apr; 47(3-4):131-5. PubMed ID: 15078429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prevalence of Candida albicans and Candida non-albicans in clinical samples during 1999-2001].
    Mujica MT; Finquelievich JL; Jewtuchowicz V; Iovannitti CA
    Rev Argent Microbiol; 2004; 36(3):107-12. PubMed ID: 15559191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fungal thigmotropism in onychomycosis and in a clear hydrogel pad model.
    Piérard GE; Piérard-Franchimont C; Quatresooz P
    Dermatology; 2007; 215(2):107-13. PubMed ID: 17684371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Onychomycosis in Casablanca (Morocco)].
    Halim I; El Kadioui F; Soussi Abdallaoui M
    J Mycol Med; 2013 Mar; 23(1):9-14. PubMed ID: 23287730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Candida onychomycosis--an evaluation of the role of Candida species in nail disease.
    Hay RJ; Baran R; Moore MK; Wilkinson JD
    Br J Dermatol; 1988 Jan; 118(1):47-58. PubMed ID: 3342176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Onychomycosis mycological profile in Abidjan (Cote d'Ivoire)].
    Konate A; Yavo W; Kassi KF; Djohan V; Angora KE; Bosson-Vanga H; Barro-Kiki P; E I H Menan
    J Mycol Med; 2014 Sep; 24(3):205-10. PubMed ID: 24751943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case of melanonychia due to Candida albicans.
    Parlak AH; Goksugur N; Karabay O
    Clin Exp Dermatol; 2006 May; 31(3):398-400. PubMed ID: 16681587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.